27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
eFFECTOR Therapeutics (NASDAQ:EFTR) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:01 PM.
Here's what investors need to know about the announcement.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Earnings
eFFECTOR Therapeutics missed estimated earnings by 71.43%, reporting an EPS of $-0.24 versus an estimate of $-0.14.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 3.41% drop in the share price the next day.
Here's a look at eFFECTOR Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.21 | -3.83 | -0.24 |
| EPS Actual | -0.22 | -0.23 | -0.17 | 0.07 |
| Revenue Estimate | 660K | 640K | 520K | 350K |
| Revenue Actual | 674K | 867K | 2.01M | 0 |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for eFFECTOR Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.